Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

The STAR*D Project results: a comprehensive review of findings.

Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR.

Curr Psychiatry Rep. 2007 Dec;9(6):449-59.

PMID:
18221624
2.

Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.

Kozel FA, Trivedi MH, Wisniewski SR, Miyahara S, Husain MM, Fava M, Lebowitz B, Zisook S, Rush AJ.

Am J Geriatr Psychiatry. 2008 Jan;16(1):58-64. doi: 10.1097/JGP.0b013e31815a43d7.

PMID:
18165462
3.

Income and attrition in the treatment of depression: a STAR*D report.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK, Shores-Wilson K, Nierenberg AA, Trivedi MH.

Depress Anxiety. 2009;26(7):622-33. doi: 10.1002/da.20541.

PMID:
19582825
4.

Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.

Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ.

J Clin Psychiatry. 2008 Aug;69(8):1246-56.

PMID:
18681756
5.

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G; STAR*D Investigators Group.

Control Clin Trials. 2004 Feb;25(1):119-42.

PMID:
15061154
6.

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.

Rush AJ, Wisniewski SR, Warden D, Luther JF, Davis LL, Fava M, Nierenberg AA, Trivedi MH.

Arch Gen Psychiatry. 2008 Aug;65(8):870-80. doi: 10.1001/archpsyc.65.8.870.

PMID:
18678792
7.

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.

Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH.

Depress Anxiety. 2009;26(7):612-21. doi: 10.1002/da.20568.

PMID:
19382183
8.

Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

Lesser IM, Castro DB, Gaynes BN, Gonzalez J, Rush AJ, Alpert JE, Trivedi M, Luther JF, Wisniewski SR.

Med Care. 2007 Nov;45(11):1043-51.

PMID:
18049344
9.

What alternatives to first-line therapy for depression are effective?

Manning JS.

J Clin Psychiatry. 2010;71 Suppl 1:10-5. doi: 10.4088/JCP.9104su1c.02.

10.

STAR*D: revising conventional wisdom.

Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA.

CNS Drugs. 2009 Aug;23(8):627-47. doi: 10.2165/00023210-200923080-00001.

PMID:
19594193
11.

Pain in depression: STAR*D study findings.

Husain MM, Rush AJ, Trivedi MH, McClintock SM, Wisniewski SR, Davis L, Luther JF, Zisook S, Fava M.

J Psychosom Res. 2007 Aug;63(2):113-22.

PMID:
17662746
12.

Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).

Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.

J Clin Psychiatry. 2009 Feb;70(2):232-7. Epub 2009 Jan 13.

PMID:
19192459
13.

Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2008 Oct;46(10):21-4. Review.

PMID:
18935932
14.

Family history of depression and therapeutic outcome: findings from STAR*D.

Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, Davis L, Balasubramani GK, Young E, Albala AA, Trivedi MH.

J Clin Psychiatry. 2009 Feb;70(2):185-95. Epub 2008 Dec 2.

PMID:
19192454
15.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

16.

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.

J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.

PMID:
19027961
17.

Limitations in efficacy of antidepressant monotherapy.

Rush AJ.

J Clin Psychiatry. 2007;68 Suppl 10:8-10.

18.

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M.

Am J Psychiatry. 2006 Nov;163(11):1905-17.

PMID:
17074942
19.
20.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525

Supplemental Content

Support Center